These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2537605)

  • 21. Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
    Jett JR; Hatfield AK; Hillman S; Bauman MD; Mailliard JA; Kugler JW; Morton RF; Marks RS; Levitt R
    Cancer; 2003 May; 97(10):2498-503. PubMed ID: 12733149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dose-response effect of drugs in the chemotherapy of small-cell bronchial carcinoma].
    Kostić D; Jelić S; Radulović S
    Srp Arh Celok Lek; 2000; 128(3-4):75-9. PubMed ID: 10932613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.
    Franciosi V; Cocconi G; Michiara M; Di Costanzo F; Fosser V; Tonato M; Carlini P; Boni C; Di Sarra S
    Cancer; 1999 Apr; 85(7):1599-605. PubMed ID: 10193952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The efficacy and side effects of chemotherapy for primary lung cancer with cisplatin and etoposide].
    Tsutsumi T; Kawakami A; Ozawa Y; Kawaguchi H; Fujii H; Sawano T; Asamoto H
    Gan To Kagaku Ryoho; 1991 May; 18(6):1003-6. PubMed ID: 1851407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer.
    Bunn PA; Kelly K
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-144-S12-148. PubMed ID: 9331140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.
    Ardizzoni A; Manegold C; Debruyne C; Gaafar R; Buchholz E; Smit EF; Lianes P; ten Velde G; Bosquee L; Legrand C; Neumaier C; King K;
    Clin Cancer Res; 2003 Jan; 9(1):143-50. PubMed ID: 12538462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combination chemotherapy of non-small cell lung cancer (NSCLC) with cisplatin (CDDP), carboquone (CQ) and prednisolone (PDN)(PPQ therapy)].
    Nakao I; Ohashi Y; Ito K; Yokoyama T; Nishi I; Kanko T; Saito T
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):217-20. PubMed ID: 2154159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination chemotherapy with etoposide, ADM, and CDDP (EAP) for advanced gastric cancer].
    Taguchi T; Ohta J; Orino M; Ohshiba S; Yamada S; Okazima K; Ohtani T; Hurukawa H; Iwanaga T; Numata N
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2191-6. PubMed ID: 2241183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preliminary report on the effect of etoposide or etoposide and CDDP on recurrent prostate cancer].
    Suzuki K; Nakamura T; Kato N; Kurita M; Nakazawa Y; Suzuki T; Imai K; Yamanaka H
    Hinyokika Kiyo; 1991 Nov; 37(11):1499-503. PubMed ID: 1767772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A myelo dysplastic syndrome (refractory anemia with excess of blasts) occurred in a patient with small cell lung cancer during complete response].
    Hatakeyama S; Kohmura K; Ebe T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Nov; 28(11):1488-93. PubMed ID: 1963199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Randomized controlled study on chemotherapy with 5-FD, ADM plus CDDP in advanced gastric carcinoma].
    Kikuchi K; Wakui A; Shimizu H; Kunii Y
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):655-62. PubMed ID: 2181941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
    Saito R; Tsuchiya S; Minato K; Ishizuka T
    Nihon Gan Chiryo Gakkai Shi; 1988 Mar; 23(3):744-51. PubMed ID: 2841389
    [No Abstract]   [Full Text] [Related]  

  • 37. [Remarkable effect of the combination therapy of etoposide, epiadriamycin, and CDDP (EAP) in the treatment of metachronous lung metastases of breast cancer--a case report].
    Kawabe T; Honda I; Kawakami Y; Fujita M; Watanabe K; Ryu M; Watanabe S; Yoshida M; Matsushita K
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2467-9. PubMed ID: 1659328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.
    Mascaux C; Paesmans M; Berghmans T; Branle F; Lafitte JJ; Lemaitre F; Meert AP; Vermylen P; Sculier JP;
    Lung Cancer; 2000 Oct; 30(1):23-36. PubMed ID: 11008007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small cell bronchogenic carcinoma: a cyclical alternating combination of epirubicin plus cisplatin and cyclophosphamide plus etoposide.
    Casadio M; Lelli G; Giordani S; Boltri B; Blotta A; Busutti L; Ramini R; Falcone F; Pannuti F
    J Chemother; 1990 Jun; 2(3):199-202. PubMed ID: 2166145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of cepharanthin on leukopenia and thrombocytopenia induced by chemotherapy in lung cancer patients].
    Suzuki R; Hara M; Shindoh J; Matsumoto S; Noda Y; Gonda H; Tanaka H; Taki F; Takagi K
    Gan To Kagaku Ryoho; 1992 May; 19(5):647-52. PubMed ID: 1316101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.